Catalyst Pharmaceuticals (NASDAQ: CPRX) was on an upswing in pre-market trading on Tuesday following the news that it will replace Mantech International Corp. (MANT) in the S&P SmallCap 600 effective September 15, before the opening bell.
The Carlyle Group (CG) is expected to close its pending acquisition of the Mantech Group soon.